Morisset Valerie
Insider CIK 1868517 · ELYM EVP, R&D and CSO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELYM Eliem Therapeutics, Inc. | S Sale | 2024-07-22 | 2024-07-23 | 30,000 | $7.98 | $239.4K | 31,317 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | S Sale | 2024-07-22 | 2024-07-23 | 39,005 | $8.07 | $314.8K | 61,317 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | S Sale | 2024-07-19 | 2024-07-23 | 10,201 | $7.09 | $72.3K | 150,322 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | S Sale | 2024-07-19 | 2024-07-23 | 50,000 | $7.24 | $362.0K | 100,322 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | S Sale | 2024-07-18 | 2024-07-19 | 38,576 | $6.93 | $267.3K | 160,523 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | S Sale | 2024-07-17 | 2024-07-19 | 3,207 | $6.91 | $22.2K | 199,099 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | S Sale | 2024-07-16 | 2024-07-17 | 50,000 | $7.13 | $356.5K | 202,306 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | S Sale | 2024-07-15 | 2024-07-16 | 42,377 | $7.01 | $297.1K | 252,306 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | S Sale | 2024-07-12 | 2024-07-16 | 50,000 | $7.07 | $353.5K | 294,683 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | S Sale | 2024-07-11 | 2024-07-11 | 50,000 | $7.11 | $355.5K | 344,683 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | S Sale | 2024-07-10 | 2024-07-11 | 50,000 | $6.83 | $341.5K | 394,683 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | S Sale | 2024-07-09 | 2024-07-11 | 5,931 | $6.66 | $39.5K | 444,683 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | S Sale | 2024-07-05 | 2024-07-09 | 12,342 | $7.06 | $87.1K | 450,614 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | S Sale | 2024-07-03 | 2024-07-03 | 50,000 | $6.76 | $338.0K | 462,956 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | M Exercise deriv | 2024-07-01 | 2024-07-03 | 7,649 | — | $0 | 10,198 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | M Exercise | 2024-07-01 | 2024-07-03 | 7,649 | — | $0 | 512,956 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | M Exercise deriv | 2024-04-05 | 2024-04-08 | 17,847 | — | $0 | 28,046 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | M Exercise | 2024-04-05 | 2024-04-08 | 17,847 | — | $0 | 505,307 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | M Exercise deriv | 2023-09-20 | 2024-03-04 | 15,297 | — | $0 | 45,893 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | M Exercise deriv | 2023-09-20 | 2024-03-04 | 5,431 | — | $0 | 0 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | M Exercise | 2023-09-20 | 2024-03-04 | 5,431 | — | $0 | 472,163 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | M Exercise | 2023-09-20 | 2024-03-04 | 15,297 | — | $0 | 487,460 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | M Exercise deriv | 2023-03-10 | 2023-03-14 | 61,191 | — | $0 | 61,190 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | M Exercise deriv | 2023-03-10 | 2023-03-14 | 255,219 | — | $0 | 5,431 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | M Exercise | 2023-03-10 | 2023-03-14 | 61,191 | — | $0 | 466,732 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | M Exercise | 2023-03-10 | 2023-03-14 | 255,219 | — | $0 | 405,541 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award deriv | 2022-10-31 | 2022-11-02 | 170,000 | — | $0 | 170,000 | SEC↗ |
| ELYM Eliem Therapeutics, Inc. | A Award deriv | 2022-01-27 | 2022-01-31 | 170,000 | — | $0 | 170,000 | SEC↗ |